C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/04 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2550962
A method of determining a potential of a diabetic patient to benefit from anti oxidant therapy for treatment of a vascular complication, the method comprising determining a haptoglobin phenotype of the diabetic patient and thereby determining the potential of the diabetic patient to benefit from said anti oxidant therapy, whereby a patient having a haptoglobin 2-2 phenotype benefits from anti oxidant therapy more than a patient having a haptoglobin 1- 2 phenotype or a patient having a haptoglobin 1-1 phenotype.
L'invention porte sur une méthode permettant de déterminer le bénéfice potentiel d'une thérapie antioxydante de traitement de complications cardio-vasculaires. Ladite méthode consiste à déterminer le phénotype d'haptoglobine du patient diabétique, et par-là, le bénéfice potentiel d'une telle thérapie. Un patient présentant un phénotype d'haptoglobine 2-2 bénéficiera plus de ladite thérapie qu'un patient présentant un phénotype d'haptoglobine 1-2 ou qu'un patient présentant un phénotype d'haptoglobine 1-1.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Rappaport Family Institute For Research In The Medical Sciences
LandOfFree
Methods of predicting a benefit of antioxidant therapy for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of predicting a benefit of antioxidant therapy for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of predicting a benefit of antioxidant therapy for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2035938